Profile
Isabel Aznarez is the founder of Stoke Therapeutics, Inc. since 2014, holding the title of Senior Vice President & Head-Research.
Dr. Aznarez is currently the Director of Oligonucleotide Therapeutics Society, Inc. since 2019.
Dr. Aznarez obtained a doctorate from the University of Toronto in 2006 and completed an undergraduate degree at Universidad De La Republica Uruguay.
Isabel Aznarez active positions
| Companies | Position | Start |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Founder | 31/05/2014 |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Director/Board Member | 31/12/2018 |
Training of Isabel Aznarez
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Universidad De La Republica Uruguay
Universidad De La Republica Uruguay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- Isabel Aznarez
















